Incyte Corporation
INCY
$98.07
-$1.97-1.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.51B | 1.37B | 1.22B | 1.05B | 1.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.51B | 1.37B | 1.22B | 1.05B | 1.18B |
| Cost of Revenue | 732.55M | 605.59M | 573.68M | 473.77M | 565.82M |
| Gross Profit | 774.29M | 760.40M | 641.85M | 579.13M | 612.88M |
| SG&A Expenses | 388.97M | 328.29M | 330.26M | 324.97M | 345.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.12B | 933.87M | 903.94M | 835.44M | 911.52M |
| Operating Income | 385.32M | 432.11M | 311.59M | 217.46M | 267.18M |
| Income Before Tax | 389.94M | 482.31M | 558.01M | 234.19M | 313.72M |
| Income Tax Expenses | 90.66M | 58.14M | 153.01M | 75.99M | 112.51M |
| Earnings from Continuing Operations | 299.28M | 424.17M | 405.00M | 158.20M | 201.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 299.28M | 424.17M | 405.00M | 158.20M | 201.21M |
| EBIT | 385.32M | 432.11M | 311.59M | 217.46M | 267.18M |
| EBITDA | 409.31M | 456.13M | 334.51M | 239.83M | 289.92M |
| EPS Basic | 1.52 | 2.17 | 2.09 | 0.82 | 1.04 |
| Normalized Basic EPS | 1.33 | 1.47 | 1.10 | 0.80 | 0.93 |
| EPS Diluted | 1.46 | 2.11 | 2.04 | 0.80 | 1.02 |
| Normalized Diluted EPS | 1.28 | 1.43 | 1.08 | 0.78 | 0.91 |
| Average Basic Shares Outstanding | 197.44M | 195.67M | 194.00M | 193.71M | 193.15M |
| Average Diluted Shares Outstanding | 204.77M | 201.43M | 198.74M | 198.20M | 197.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |